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Gold (198Au) foils brachytherapy use on canine
skin tumor
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Summary
This study showed a skin squamous cell carcinoma clinical case
from 8-years-old female weimaranner, treated by gold-198 foil
brachytherapy. The aims were to evaluate special radioactive
mould performed to be used on Veterinary practioners and, its
efficiency on one case of  skin tumor treatment in dog. The
method showed efficacy on the skin tumor treatment and
radiological protection especially for the professional team
involved, low cost and better radiobiological results when it was
compared with standard treatment using others radioactive
elements.
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Introduction
Canine skin squamous cell
carcinoma (SCC) is frequently found
on the limbs, however, the trunk, head,
and neck are commonly involved 1. The
majority of the dogs with skin SCC
have a good prognosis after tumor
surgical excision. Histological evaluation
is important and most of the time,
determine the prognosis2. Actually, if
the tumor is well differentiated and
surgical excision is complete, the rate
of  recurrence and metastasis are low.
However, if tumor is histologically
poorly differentiated, metastasis is
more likely to occur3, and consequently
cisplatin chemotherapy can be
considered4. Thereafter, if histological
residual SCC evidences exists, radiation
therapy should be employed for the
treatment5. The cutaneous SCC
response to radiation therapy has not
been well characterized. Protocols like
those, recommended for oral SCC
treatment, may be considered
appropriated for this case 6. Radiation
therapy and cisplatin chemotherapy
combination may be considered
adequate, when patients with SCC were
both unrespectable and anaplastic8.
Radioactive elements such as
Radon (222Rd) and Gold (198Au) have
been employed for years in veterinary
brachytherapy, generally as individual
seeds in permanent implant
forms8,9,10,11. However, this procedure
shows difficulties, especially concerned
in the seed distribution inside the lesion.
In fact, this procedure compromises
the radiation dose distribution because
strong dose gradients, with high and
low alternate points  are induced12. This
radiation dose heterogeneous
distribution leads to recurrence of the
skin tumor and to a poor prognosis.
Nowadays, Iridium (192Ir) is more
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Material and Method
Case Report
An 8-years-old female
Weimaranner purebred dog was
attended at the Veterinary Hospital of
Universidade Estadual Paulista (Unesp)
- Araçatuba city, Sªo Paulo state -
Brazil, with chronic exulceration in the
right thoracic limb skin at the carpal
region of  five months history. The
prescribed treatment prior to referral
consisted of several topically
administered broad-spectrum
antibiotics with no improvement.
Dermatological examination revealed
a single and chronic exulceration,
erythematous and hairless with round
shape and elevated borders (Figure 1).
The lesion size had about 20 cm2, and
there was no evidence of other physical
abnormalities. The presumptive
diagnosis was skin SCC based on the
history. A tissue fragment with 5 mm
of diameter was extracted from the
lesion border and submitted to
histopathological evaluation, which
confirmed skin SCC.
Treatment performed
The animal reported has been
treated with teletherapy followed by
brachytherapy. The dog was submitted
to intravenous general anesthesia with
chlorpromazine (Amplictil  Rhodia)
(1.0 mg/kg of body weight, IV) and
thiopental sodium (Thionembutal 
Abbott) (12.5 mg/kg of body weight,
IV) for each session. Teletherapy was
performed in a cobalt (60Co) therapy
unity, divided in 4 sessions. The affected
area received a radiation dose of 500
cGy at 0.5 cm deepness (Cobalt-60
buildup) in each session. The first two
sessions were performed in two
consecutive days and the last two
sessions, 7 days after in a total dose of
2,000 cGy. The radiation field reached
a 6.0 cm X 8.0 cm surface area, which
covered the entire tumor, and at the
same time guaranteed safety margins.
A material with the density equal to the
human tissue (transparent bolus) and
thickness to 0.5 cm was placed on the
tumor 11 to allow a maximum region
dose (buildup) in the tumor level
(Figure 2).
Brachytherapy was performed
one week after the fourth teletherapy
session. A radioactive mould was
manufactured with a Gold (198Au) foil
in a disc shape of 2.76 cm radius which
covered totally the tumor area. The
mould was fixed on the tumor by an
adhesive tape during the treatment
period of  55 hours. The mould initial
activity was 27.0 milicuries (mCi),
which provides an initial dose rate of
60 cGy/h close to the center and of
17.5 cGy/h at the mold periphery. The
radiation dose released under the
mould level varied with the distance
to the radioactive disc center and the
treatment deepness (d), as shown in
Table 1.
Then, the total radiation dose
was composed of teletherapy and
brachytherapy close to the tumor
center was 4,500 cGy. The
brachytherapy did not require
anesthesia. The Elizabethan collar was
used to prevent the patient from
licking and scratching. The second
biopsy was done in the treatment
ending, it showed queratinized
stratificated epithelium and also an
inflammatory process with
mononuclear cells distribution mainly
around of  the pilous foliculus.
After 4 months, it was observed
commonly used in a wire form and
less frequently as the seed form13.
The objectives of this study
were: to determine the efficacy of
Gold (198Au) foils moulds in skin SCC
in a dog and to evaluate the radiation
dose distribution in the lesion plane.
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a small lesion of circular appearance
of about 1.0 cm diameter in the
periphery of the irradiated field
suggesting a residual lesion area. So, a
second biopsy specimen was extracted
from these area, and again, diagnosis
of skin SCC was made. The decision
was to repeat the brachytherapy
procedure. However, at this time the
radioactive material was distributed in
two concentric distinct regions as
shown in Figure 3.
Figure 3
Representation of the radioactive mold.
Figure 1
Illustration of the lesion before the treatment
Figure 2
Illustration of the radiation field in the teletherapy  (bolus use).
Figure 4
Skin reactions 4 weeks after the brachytherapy
Figure 5
Illustration of the treated area, 3 years after the end of
the radiotherapy.
The initial mould activity was
41.0 mCi, which provided an uniform
initial dose rate of 58.0 cGy/h in all
of the mould extension due to the
activity difference between the internal
and external ring. The treatment period
(attachment of mold in the lesion) last
seven consecutively days
(uninterrupted) and the released
radiation dose at 0.5 cm below the
mould plane was 4,500 cGy15,16.
Between the mould base and the
external surface of the lesion it was
placed a material (transparent bolus) at
same as teletherapy.
Radioactive Mould Manufacture Procedure
Non-radioactive Gold (197Au)
used in the treatment, consisted of a
rectangular shape foil of 0.00125cm
thickness, manufactured in the
specialized Brazilian market for medical
Gold (198Au) foils brachytherapy use on canine skin tumor
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Table 1
Radiation dose released in brachitherapy
Units Radiation Dose (cGy)
d (cm) Radius = 1.0cm Radius = 2.0cm Radius = 2.76cm
0.5 2,500 1,150 730
1.0 1,200  620 430
Results, Discussion and
Conclusion
The canine skin SCC is a
radiosensitive tumor and responds to
a wide range of dose levels, as well as
occurred with mastocytomas24. The
animal studied here had tolerated very
well the Cobalt (60Co) teletherapy and
Gold (198Au) brachytherapy. Some
studies had described the use of other
radioactive elements with good
results1,5,7,12,13,25,26. In our
knowledgement, this case report is the
first one with the use of this shape of
radioactive gold.
On the early periods after
teletherapy, skin reaction was not
observed in agreement to the
literature3,20. Erythema and dry
desquamation were observed three
weeks after the end of  teletherapy.
These skin reactions, actinic dermatitis,
are frequently observed in therapies
use. Manufacturer data indicate a
99.90% chemical clarity in the gold
metal mass that had been confirmed
by x-ray fluorescence and electronic
microscopic analyses, performed by
the metallurgical laboratory of Instituto
de Pesquisas EnergØticas e Nucleares
(IPEN) in Sªo Paulo (SP)  Brazil17.
At the first brachytherapy, a disc
with 5.50 cm of diameter was
withdrawn from the rectangular foil.
At the second brachytherapy, the foil
was cut out in a ring shape as shown in
Figure 3. Gold (197Au) activation was
performed in the IEA-R1 reactor of
IPEN. The activation homogenous
was checked by measurement of the
activity concentration distribution
(mCi/g) using small pieces of the foil
sample. For each piece it had been
measured its mass and its total activity.
The analysis showed the activation
homogenous was inside of the desired
quality. A second approach had been
made by means of a gamma scanning
of the Gold (198Au) foil. The
spectrometry also showed that the
homogenous was acceptable for
brachytherapy purposes. The activation
time of the gold (197Au) foils in the
reactor was based on the neutron flux
at the irradiation position, the required
dose for the treatment, the tumor area
and the foil dimension18.
The Computer System Micro
Shield Version 419 was used during all
the preliminary study phases of the
dose distribution at the lesion level and
its geometric morphology. In order to
verify the ideal conditions, a
radiographic film was exposed to the
radioactive mould, and the obtained
image was analyzed in an optical
densitometer. Optical density study
showed a good agreement to the
desired dose distribution, which
demonstrated the radioactive viability
of the mould manufactured.
The radiation dose estimated for
the treatment was based on
brachytherapy protocols currently in
use20 and the radium dosage rules
recommended by the Manchester
System21, which establishes the quantity
of milligrammes-hour of the used
radioactive element. Gold (198Au)
radioactive decay and released dose
attenuation were appreciated as a time
function and thus, estimated the
necessary treatment period for the
desirable radiation dose liberation22,23.
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with radioactive elements18,27. After
mould removes, the following signs
were present: hair loss and thinning
epidermis were observed four weeks
after the first schedule brachytherapy
(Figure 4). Skin healing reactions
occurred within 30 days and none other
physical abnormalities were evident.
Biopsies were taken from
irradiated tissue in our patient, and
histological examination revealed
recurrence of the skin SCC. This fact
was an important procedure to indicate
an additional schedule of
brachytherapy with radioactive gold
concentric rings. After this therapy the
dog was considered clinically free of
tumor. Afterwards, a new biopsy was
taken of marginal lesion and reveled
that marginal board was healthy.
Although others therapeutic
possibilities has been already
mentioned3,4,25 the proposed treatment
here showed the advantage of not
been invasive. The lesion area (carpals
anterior face) is a local of difficult
healing because it shows a great tension
at wounded borders. In the majority
of the cases this fact gives rise to the
rupture of sutures, moreover it does
not guarantee free surgical borders of
tumor2. These facts confirm the
advantages of  the applied methods.
In fact, it was observed the skin
and hair colors changing 60 days after
the treatment. There was partial hair
growth, leukotrichya and a skin scar
remained in later periods (Figure 5).
The clinical observations after
the brachytherapy showed therapeutic
results similar to the ones obtained with
commonly radioactive implant moulds
used in the large variety of specialized
centers in the small animal cancer
treatment2,5,25.
The radioactive material use in
concentric rings format, provided
greater uniformity, in the dose
distribution, better than seed
implants14,17,28. The radioactive material
time handling using a disc shape was
lower than that observed with the use
of  seeds. Actually, it has been
demonstrated a lower radiation
exposition risk for the professionals
involved in the treatment. Thereafter,
the brachytherapy techniques in several
cases avoid the surgical mutilations,
which require a great skin area removal
or even the indication of
euthanasia4,5,12.
The treatment was well
tolerated by the animal and the
radioactive mold confection irradiated
in the IEA-R1 nuclear reactor, although
requiring a multidisciplinary team, can
be easily performed. Finally, the
proposed procedure gives rise to a
good option for skin tumor treatment
against recurrent lesions.
In conclusion, the development
of a time-dose schedule that gives a
high degree of cures, without a
damaging effect upon the patient, has
been the primary goal of most
radiotherapists. An ideal therapy
schedule should afford a time-dose
relationship that delivers a destructive
dose to the tumor, spares the normal
tissue as much as possible, and requires
a minimal number of visits by the
animal patients to the therapist for
treatment. Moreover, to offer the
veterinary patient cancer holders an
additional and reliable treatment option.
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Resumo
Este trabalho relata um caso clínico de carcinoma escamo celular
cutâneo em um cªo da raça Weimaraner, fŒmea, 8 anos de idade
tratado utilizando-se braquiterapia com folhas de Ouro-198. Os
objetivos deste relato foram: avaliar o uso de um molde
radioativo confeccionado para uso veterinÆrio e sua eficÆcia no
tratamento de um tumor de pele em cªo. O mØtodo demonstrou
ser eficaz no tratamento do tumor, mostrou ser uma prÆtica
segura para a equipe profissional envolvida, com baixos custos e
resultado radiobiológico superior quando comparado com o
tratamento padrªo utilizado com outros elementos radioativos.
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